Literature DB >> 21792692

Clinical characteristics of fulminant type 1 diabetes associated with pregnancy in China.

Lan Liu1, Jiping Mao, Zeyuan Lu, Xiaojie Yan, Xiaosu Bai, Yiyi Ye, Gang Zou.   

Abstract

To report 12 cases of pregnancy-associated fulminant type 1 diabetes mellitus (PF) found in China from 2003 to 2010. The clinical and biochemical characteristics of these cases with PF were compared with a group of cases of child-bearing age with fulminant type 1 diabetes that was not associated with pregnancy (NPF). The clinical and biochemical characteristics of 12 PF cases were analyzed retrospectively and then compared with those characteristics of 20 NPF cases in China. The difference between Chinese and Japanese PF cases was investigated. The mean values of the characteristics from PF and NPF cases in China, including postprandial serum C-peptide concentration, plasma glucose concentration, and serum chloride were different. Compared to the 22 PF cases in Japan, the mean age of these 12 PF cases was much younger. The mean fasting and postprandial serum C-peptide concentration level were lower, and the mean HbA1c levels was higher in 12 PF cases in China. Eight of 12 PF cases in China developed the disease during pregnancy. Other four PF case developed the disease within 2 weeks after delivery. 12 PF cases in China showed more severe beta-cell destruction, the prognosis of their fetuses was extremely poor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21792692     DOI: 10.1007/s12020-011-9496-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  8 in total

1.  A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group.

Authors:  A Imagawa; T Hanafusa; J Miyagawa; Y Matsuzawa
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

2.  Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice.

Authors:  Lola Weiss; Steve Bernstein; Richard Jones; Ravi Amunugama; David Krizman; Lellean Jebailey; Osnat Almogi-Hazan; Osnat Hazan; Zhanna Yekhtin; Janna Yachtin; Reut Shiner; Israel Reibstein; Elizabeth Triche; Shimon Slavin; Reuven Or; Eytan R Barnea
Journal:  Endocrine       Date:  2011-03-22       Impact factor: 3.633

Review 3.  Fulminant type 1 diabetes mellitus.

Authors:  Akihisa Imagawa; Toshiaki Hanafusa
Journal:  Endocr J       Date:  2006-07-28       Impact factor: 2.349

4.  Fulminant type 1 diabetes: report of two cases.

Authors:  Tong Wang; Xin-hua Xiao; Wen-hui Li; Tao Yuan; Xiao-fang Sun; Heng Wang
Journal:  Chin Med J (Engl)       Date:  2008-01-20       Impact factor: 2.628

5.  Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy.

Authors:  I Shimizu; H Makino; A Imagawa; H Iwahashi; Y Uchigata; A Kanatsuka; E Kawasaki; T Kobayashi; A Shimada; T Maruyama; T Hanafusa
Journal:  J Clin Endocrinol Metab       Date:  2005-11-08       Impact factor: 5.958

6.  Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese.

Authors:  Chao Zheng; Zhiguang Zhou; Lin Yang; Jian Lin; Gan Huang; Xia Li; Weidong Zhou; Xiangbing Wang; Zhenqi Liu
Journal:  Diabetes Metab Res Rev       Date:  2010-11-10       Impact factor: 4.876

7.  Fulminant type 1 diabetes: a nationwide survey in Japan.

Authors:  Akihisa Imagawa; Toshiaki Hanafusa; Yasuko Uchigata; Azuma Kanatsuka; Eiji Kawasaki; Tetsuro Kobayashi; Akira Shimada; Ikki Shimizu; Tetsuya Toyoda; Taro Maruyama; Hideichi Makino
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

8.  Association of fulminant type 1 diabetes with pregnancy.

Authors:  I Shimizu; H Makino; H Osawa; E Kounoue; A Imagawa; T Hanafusa; E Kawasaki; Y Fujii
Journal:  Diabetes Res Clin Pract       Date:  2003-10       Impact factor: 5.602

  8 in total
  1 in total

1.  Clinical study of pregnancy-associated fulminant type 1 diabetes.

Authors:  Lan Liu; Wenjuan Jia; Ruike Liu; Jie Shen
Journal:  Endocrine       Date:  2018-03-02       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.